ConductScience.org, home

Paper42898534PubMed

Antidepressant effects of artemisinin and its derivatives: a systematic review and meta-analysis of randomized controlled animal studies.

Tian Y and 3 others. Front Pharmacol, 2026.

Cite this record

ConductScience Library. Antidepressant effects of artemisinin and its derivatives: a systematic review and meta-analysis of randomized controlled animal studies. Papers, record 42898534. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42898534

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antidepressant effects of artemisinin and its derivatives: a systematic review and meta-analysis of randomized controlled animal studies.
Journal
Front Pharmacol
Year
2026
Publication types
Journal Article, Systematic Review
Revised in PubMed
2026-10-22

Source PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tian YYuan
2Zhang HHaiping
3Zhang XXu
4Wang LLuyao

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122300229Improving cognitive outcome in cerebral malaria: insights from clinical and experimental research.Cent Nerv Syst Agents Med Chem2011https://conductscience.org/library/papers/22300229PubMed
233782057The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.BMJ2021https://conductscience.org/library/papers/33782057PubMed
325541544Meta-analyses of animal studies: an introduction of a valuable instrument to further improve healthcare.ILAR J2014https://conductscience.org/library/papers/25541544PubMed
424667063SYRCLE's risk of bias tool for animal studies.BMC Med Res Methodol2014https://conductscience.org/library/papers/24667063PubMed
524411643Biomedical research: increasing value, reducing waste.Lancet2014https://conductscience.org/library/papers/24411643PubMed
639343990The Potential Role of Artemisinins Against Neurodegenerative Diseases.Am J Chin Med2024https://conductscience.org/library/papers/39343990PubMed
728058794Basics of meta-analysis: I2 is not an absolute measure of heterogeneity.Res Synth Methods2017https://conductscience.org/library/papers/28058794PubMed
833038880Cognitive dysfunctions in depression - significance, description and treatment prospects.Psychiatr Pol2020https://conductscience.org/library/papers/33038880PubMed
927733935Effectiveness of antipsychotics used in first-episode psychosis: a naturalistic cohort study.BJPsych Open2016https://conductscience.org/library/papers/27733935PubMed
1041181594Artemisinin exerts antidepressant-like effects via activation of AKT and ERK signaling pathways.Front Pharmacol2025https://conductscience.org/library/papers/41181594PubMed
1140943352Artemisinin and Its Derivatives from Molecular Mechanisms to Clinical Applications: New Horizons Beyond Antimalarials.Int J Mol Sci2025https://conductscience.org/library/papers/40943352PubMed
1238552734Dihydroartemisinin Protects Mice from CUMS-induced Depression-like Behaviors by Regulating Gut Microbes.Neuroscience2024https://conductscience.org/library/papers/38552734PubMed
1329470495Reproducibility of preclinical animal research improves with heterogeneity of study samples.PLoS Biol2018https://conductscience.org/library/papers/29470495PubMed
1437713568Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management.World Psychiatry2023https://conductscience.org/library/papers/37713568PubMed
1535026139Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.Lancet Psychiatry2022https://conductscience.org/library/papers/35026139PubMed
1630200699[Application of three artemisinin derivatives in neuropathic pain: evaluating co-curation of nociceptive and emotional syndromes in spinal cord ligation mice].Zhongguo Zhong Yao Za Zhi2018https://conductscience.org/library/papers/30200699PubMed
1730025524The association of depression and all-cause and cause-specific mortality: an umbrella review of systematic reviews and meta-analyses.BMC Med2018https://conductscience.org/library/papers/30025524PubMed
1820361022Publication bias in reports of animal stroke studies leads to major overstatement of efficacy.PLoS Biol2010https://conductscience.org/library/papers/20361022PubMed
1935683033Artemisinin Attenuates Amyloid-Induced Brain Inflammation and Memory Impairments by Modulating TLR4/NF-κB Signaling.Int J Mol Sci2022https://conductscience.org/library/papers/35683033PubMed
2037331451Effects of Artemisia annua L. on postmenopausal syndrome in ovariectomized mice.J Ethnopharmacol2023https://conductscience.org/library/papers/37331451PubMed

See all 48 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42898534

GET https://conductscience.org/api/papers/v1/42898534/references?page=2